With Pfizer’s stock down sharply, an activist investor is pushing for CEO Albert Bourla to improve performance.

GPN Vaccines is thrilled to announce the appointment of Dr. Bruce Forrest as its new Chief Scientific Officer (CSO). Bruce has over 30 years of global leadership experience in Pharmaceutical ...

Canada will not be providing Novavax for the 2024/25 season, leaving those who would have preferred an alternative to the ...

GSK filed two lawsuits at the US District of Delaware on 15 October saying that Moderna’s mRNA vaccine product Spikevax ...

In an effort to increase access to immunization services and strengthen the healthcare workforce, the Pharmacy Technician Certification Board (PTCB) is excited to announce the launch of a new grant ...

Thermo Fisher Scientific to establish bioprocess design centre in Hyderabad, boosting local pharmaceutical industry with ...

Georgina Peacock vividly remembers a night when she admitted 20 babies, all struggling to breathe, into the hospital where she was doing her pediatric medical training. The illness that was ...

The global training hub To begin ... sharing has not yet happened with the vaccines, except for a couple of companies. Though major mRNA producers, like Pfizer and Moderna, have not approved ...

The mRNA Revolution When the COVID-19 pandemic struck, the world's medical community initially prepared for a disaster of the scale of the Spanish Flu, which struck during WW1 and killed 50 million ...

The company’s first product, a palatable anti-parasitic drug, made to taste like toffee, united Pfizer’s skills as a chemist with Erhart’s training ... get a COVID-19 vaccine approved ...

Many life-science companies—including Pfizer, AstraZeneca, and Janssen—already deploy ... gathering data about which ones ...